Cited by 1,086Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchPrion Diseases and Protein Misfolding

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.

A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease.

Open access

Hensley, K, Carney, J M, Mattson, M P, Aksenova, M, Harris, M, Wu, J F, Floyd, R A, Butterfield, D A·1994·Proceedings of the National Academy of Sciences

DOI 10.1073/pnas.91.8.3270PMC PMC43558

Open this paper in CoChat — free account

Abstract

beta-Amyloid is a 39- to 43-amino-acid neurotoxic peptide that aggregates to form the core of Alzheimer disease-associated senile (amyloid) plaques. No satisfactory hypothesis has yet been proposed to explain the mechanism of beta-amyloid aggregation and toxicity. We present mass spectrometric and electron paramagnetic resonance spin trapping evidence that beta-amyloid, in aqueous solution, fragments and generates free radical peptides. beta-Amyloid fragments, at concentrations that previously have been shown to be neurotoxic to cultured neurons, can inactivate oxidation-sensitive glutamine synthetase and creatine kinase enzymes. Also, salicylate hydroxylation assays indicate that reactive oxygen species are generated by the beta-amyloid-(25-35) fragment during cell-free incubation. These results are formulated into a free radical-based unifying hypothesis for neurotoxicity of beta-amyloid and are discussed with reference to membrane molecular alterations in Alzheimer disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1073/pnas.91.8.3270

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619
The molecular pathology of Alzheimer's disease
Selkoe, D. J. (1991) · Neuron · doi:10.1016/0896-6273(91)90052-2 · Cited by 2,708
Neurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin Neuropeptides
Yankner, B. A., Duffy, L. K., & Kirschner, D. A. (1990) · Science · doi:10.1126/science.2218531 · Cited by 1,975
Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state
Pike, C., Burdick, D., Walencewicz, A., Glabe, C., & Cotman, C. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-04-01676.1993 · Cited by 1,417
Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease.
Smith, C. D., Carney, J. M., Starke-Reed, P. E., Oliver, C. N., Stadtman, E. R., Floyd, R. A., & Markesbery, W. R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.23.10540 · Cited by 1,296
Self-citation
Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs.
Burdick, D., Soreghan, B., Kwon, M., Kosmoski, J., Knauer, M., Henschen, A., Yates, J., Cotman, C., & Glabe, C. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)48529-8 · Cited by 1,014
Oxidative damage to brain proteins, loss of glutamine synthetase activity, and production of free radicals during ischemia/reperfusion-induced injury to gerbil brain.
Oliver, C., Starke-Reed, P. E., Stadtman, E. R., Liu, G. J., Carney, J. M., & Floyd, R. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.13.5144 · Cited by 771
Self-citation
Reversal of age-related increase in brain protein oxidation, decrease in enzyme activity, and loss in temporal and spatial memory by chronic administration of the spin-trapping compound N-tert-butyl-alpha-phenylnitrone.
Carney, J. M., Starke-Reed, P. E., Oliver, C., Landum, R. W., Cheng, M. S., Wu, J., & Floyd, R. A. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.9.3633 · Cited by 724
Self-citation
Free radical damage to protein and DNA: Mechanisms involved and relevant observations on brain undergoing oxidative stress
Floyd, R. A., & Carney, J. M. (1992) · Annals of Neurology · doi:10.1002/ana.410320706 · Cited by 539
Self-citation
β-Amyloid precursor protein metabolites and loss of neuronal Ca2+ homeostasis in Alzheimer's disease
Mattson, M. P., Barger, S. W., Cheng, B., Lieberburg, I. M., Smith‐Swintosky, V. L., & Rydel, R. E. (1993) · Trends in Neurosciences · doi:10.1016/0166-2236(93)90009-b · Cited by 518
Self-citation

Flagged first, then by citations

Show all 23 references

Research works printed but not linked: 5

[9]Oliver, C. N., Starke-Reed, P. E., Stadtman, E. R., Liu, G. J., Carney, J. M. & Floyd, R. A. (1990) Proc. Natl. Acad. Sci. USA 87, 5144–5147.
[11]Miller, R. E., Hadenberg, R. & Gersham, H. (1978) Proc. Natl. Acad. Sci. USA 75, 1418–1422.
[13]Janzen, E. G. (1980) in Free Radicals in Biology, ed. Pryor, W. A. (Academic, New York), Vol. 4, pp. 115-154.
[19]Carney, J. M., Starke-Reed, P. E., Oliver, C. N., Landum, R. W., Cheng, M. S., Wu, J. F. & Floyd, R. A. (1991) Proc. Natl. Acad. Sci. USA 88, 3633–3636.
[27]Smith, C. D., Carney, J. M., Starke-Reed, P. E., Oliver, C. N., Stadtman, E. R., Floyd, R. A. & Markesbery, W. R. (1991) Proc. Natl. Acad. Sci. USA 88, 10540–10543.

Sorted by citations

Items 401–500 of 1,000

Redox Control of the Ubiquitin-Proteasome System: From Molecular Mechanisms to Functional Significance
Kriegenburg, F., Poulsen, E. G., Koch, A., Krüger, E., & Hartmann‐Petersen, R. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3590 · Cited by 77
Peculiar Stability of Amino Acids and Peptides from a Radical Perspective
Watts, Z. I., & Easton, C. J. (2009) · Journal of the American Chemical Society · doi:10.1021/ja9027583 · Cited by 75
Oxidative stress in Alzheimer's disease: Primary villain or physiological by-product?
Sutherland, G. T., Chami, B., Youssef, P., & Witting, P. K. (2013) · Redox Report · doi:10.1179/1351000213y.0000000052 · Cited by 80
Protective Effects of Piceatannol against Beta‐Amyloid–Induced Neuronal Cell Death
Kim, H. J., Lee, K. W., & Lee, H. J. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1397.051 · Cited by 75
Resveratrol Oligomers from Vitis amurensis Attenuate .BETA.-Amyloid-Induced Oxidative Stress in PC12 Cells
Jang, M. H., Piao, X. L., Kim, H. Y., Cho, E., Baek, S. H., Kwon, S. W., & Park, J. H. (2007) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.30.1130 · Cited by 75
Non-cholinergic Effects of Huperzine A: Beyond Inhibition of Acetylcholinesterase
Zhang, H., Yan, H., & Tang, X. C. (2007) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-007-9163-z · Cited by 74
Toxic Role of K+Channel Oxidation in Mammalian Brain
Cotella, D., Hernández-Enríquez, B., Wu, X., Li, R., Pan, Z., Leveille, J., Link, C. D., Oddo, S., & Sesti, F. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.6153-11.2012 · Cited by 76
Kinetics of adsorption of β-amyloid peptide Aβ(1–40) to lipid bilayers
Kremer, J. J., & Murphy, R. M. (2003) · Journal of Biochemical and Biophysical Methods · doi:10.1016/s0165-022x(03)00103-9 · Cited by 74
Red cell perturbations by amyloid β-protein
Rajadas, J., Kusiak, J. W., Chrest, F. J., Demehin, A. A., Jayaraman, M., Wersto, R. P., Nagababu, E., Ravi, L. B., & Rifkind, J. M. (2003) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(03)00101-6 · Cited by 74
Resveratrol Acts Not through Anti-Aggregative Pathways but Mainly via Its Scavenging Properties against Aβ and Aβ-Metal Complexes Toxicity
Granzotto, A., & Zatta, P. F. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021565 · Cited by 74
Chemotactic-like receptors and Aβ peptide induced responses in Alzheimer's Disease
Lorton, D. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00092-0 · Cited by 73
Free-radical scavenging by tryptophan and its metabolites through electron transfer based processes
Pérez‐González, A., Alvarez-Idaboy, J. R., & Galano, A. (2015) · Journal of Molecular Modeling · doi:10.1007/s00894-015-2758-2 · Cited by 77
Pathogenesis of feline diabetes mellitus
O’Brien, T. D. (2002) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(02)00265-4 · Cited by 72
Novel Molecular Hybrids of N-Benzylpiperidine and 1,3,4-Oxadiazole as Multitargeted Therapeutics to Treat Alzheimer’s Disease
Sharma, P. A., Tripathi, A., Tripathi, P. N., Singh, S. S., Singh, S. P., & Shrivastava, S. K. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00430 · Cited by 75
The molecular mechanisms of the anti-amyloid effects of phenols
Shoval, H., Lichtenberg, D. A., & Gazit, E. (2007) · Amyloid · doi:10.1080/13506120601116674 · Cited by 71
Protective effect of 4′, 5-dihydroxy-3′,6,7-trimethoxyflavone fromArtemisia asiaticaagainst Aβ-induced oxidative stress in PC12 cells
Heo, H.-J., Cho, H., Hong, B.-S., Kim, H., Kim, E.-K., Kim, B., & Shin, D.-H. (2001) · Amyloid · doi:10.3109/13506120109007362 · Cited by 71
Zinc and Health: Current Status and Future Directions
Hambidge, M. (2000) · Cited by 70
Amyloid-β Peptide Nitrotyrosination Stabilizes Oligomers and Enhances NMDAR-Mediated Toxicity
Guivernau, B., Bonet, J., Valls-Comamala, V., Bosch-Morató, M., Godoy, J. A., Inestrosa, N. C., Perálvarez-Marín, A., Fernández-Busquets, X., Andreu, D., Oliva, B., et al. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.1081-16.2016 · Cited by 69
The Potential Role of Ferroptosis in Alzheimer’s Disease
Zhang, G., Zhang, Y.-R., Shen, Y., Wang, Y., Zhao, M. L., & Sun, L. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201369 · Cited by 71
Physicochemical Insights on the Free Radical Scavenging Activity of Sesamol: Importance of the Acid/Base Equilibrium
Galano, A., Alvarez-Idaboy, J. R., & Francisco‐Márquez, M. (2011) · The Journal of Physical Chemistry B · doi:10.1021/jp208315k · Cited by 70
Increased mitochondrial superoxide generation in neurons from trisomy 16 mice: a model of Down’s syndrome
Schuchmann, S., & Heinemann, U. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00226-9 · Cited by 69
Heparan sulfate and chondroitin sulfate glycosaminoglycan attenuate β-amyloid(25–35) induced neurodegeneration in cultured hippocampal neurons
Woods, A. G., Cribbs, D. H., Whittemore, E. R., & Cotman, C. W. (1995) · Brain Research · doi:10.1016/0006-8993(95)00775-l · Cited by 56
Calcium-sensing receptor antagonist (calcilytic) NPS 2143 specifically blocks the increased secretion of endogenous Aβ42 prompted by exogenous fibrillary or soluble Aβ25–35 in human cortical astrocytes and neurons—Therapeutic relevance to Alzheimer's disease
Armato, U., Chiarini, A., Chakravarthy, B., Chioffi, F., Pacchiana, R., Colarusso, E., Whitfield, J. F., & Dal Prà, I. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.04.020 · Cited by 68
The protective and therapeutic effects of vinpocetine, a PDE1 inhibitor, on oxidative stress and learning and memory impairment induced by an intracerebroventricular (ICV) injection of amyloid beta (aβ) peptide
Shekarian, M., Komaki‬, A., Shahidi, ‬., Sarihi, A., Salehi, I., & Raoufi, S. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.112512 · Cited by 68
Overexpression of Glutathione Peroxidase Increases the Resistance of Neuronal Cells to Aβ‐Mediated Neurotoxicity
Barkats, M., Millecamps, S., Abrioux, P., Geoffroy, M., & Mallet, J. J. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0751438.x · Cited by 68
The promotion of iron-induced generation of reactive oxygen species in nerve tissue by aluminum
Bondy, S. C., & Kirstein, S. L. (1996) · Molecular and Chemical Neuropathology · doi:10.1007/bf02815093 · Cited by 68
Cholinergic Stimulation of AP-1 and NFκB Transcription Factors Is Differentially Sensitive to Oxidative Stress in SH-SY5Y Neuroblastoma: Relationship to Phosphoinositide Hydrolysis
Li, X., Song, L., & Jope, R. S. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-19-05914.1996 · Cited by 68
Ischemia/reperfusion-induced changes in membrane proteins and lipids of gerbil cortical synaptosomes
Hall, N. C., Carney, J. M., Cheng, M. S., & Butterfield, D. A. (1995) · Neuroscience · doi:10.1016/0306-4522(94)00385-i · Cited by 68
Self-citation
Neem Derivatives Inhibits Tau Aggregation
Gorantla, N. V., Das, R. R., Mulani, F. A., Thulasiram, H. V., & Chinnathambi, S. (2019) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-190118 · Cited by 69
Modifiable, Non-Modifiable, and Clinical Factors Associated with Progression of Alzheimer’s Disease
Loeffler, D. A. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201182 · Cited by 71
Kynurenines, neurodegeneration and Alzheimer’s disease
Kincses, Z. T., Toldi, J., & Vécsei, L. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01123.x · Cited by 70
Copper, Ceruloplasmin and Superoxide Dismutase in Patients with Alzheimer’s Disease
Snædal, J., Kristinsson, J., Gunnarsdóttir, S. A., Ólafsdóttir, A., Baldvinsson, M., & Jóhannesson, T. (1998) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000017067 · Cited by 67
Amyloid-β, tau alterations and mitochondrial dysfunction in Alzheimer disease: the chickens or the eggs?
Smith, M. (2002) · Neurochemistry International · doi:10.1016/s0197-0186(01)00123-1 · Cited by 69
Ursolic Acid of Origanum majorana L. Reduces Aâ-induced Oxidative Injury
Heo, H. J., Cho, H., Hong, B.-S., Kim, H. K., Heo, T., Kim, E.-K., Kim, S.-K., Kim, C., & Shin, D.-H. (2002) · Molecules and Cells · doi:10.1016/s1016-8478(23)14997-1 · Cited by 67
Permeability transition pore-mediated mitochondrial superoxide flashes mediate an early inhibitory effect of amyloid beta1−42 on neural progenitor cell proliferation
Hou, Y., Ghosh, P., Wan, R., Ouyang, X., Cheng, H., Mattson, M. P., & Cheng, A. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.11.002 · Cited by 66
Self-citation
Amyloid-β binds catalase with high affinity and inhibits hydrogen peroxide breakdown
Milton, N. G. N. (1999) · Biochemical Journal · doi:10.1042/bj3440293 · Cited by 65
β-Amyloid-Induced Endothelial Necrosis and Inhibition of Nitric Oxide Production
Sutton, E. T., Hellermann, G., & Thomas, T. (1997) · Experimental Cell Research · doi:10.1006/excr.1996.3440 · Cited by 65
Sources and triggers of oxidative damage in neurodegeneration
Angelova, P. R. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.07.003 · Cited by 67
The Role of Hypoxia-Inducible Factor 1 in Mild Cognitive Impairment
Iyalomhe, O., Swierczek, S. I., Enwerem, N. Y., Chen, Y., Adedeji, M. O., Allard, J. S., Ntekim, O. E., Johnson, S. M., Hughes, K., Kurian, P., et al. (2016) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-016-0440-6 · Cited by 64
The neurotoxicity of amyloid beta protein in aged primates
McKee, A. C., Kawall, N. W., Schumacher, J. S., & Beal, M. F. (1998) · Amyloid · doi:10.3109/13506129809007283 · Cited by 64
Aβ[25–35] Peptide and Iron Promote Apoptosis in Lymphocytes by an Oxidative Stress Mechanism: Involvement of H2O2, Caspase-3, NF-κB, p53 and c-Jun
Velez-Pardo, C., Garcia Ospina, G., & Jimenez del Rio, M. (2002) · NeuroToxicology · doi:10.1016/s0161-813x(02)00081-5 · Cited by 63
Anti-Alzheimer’s Molecules Derived from Marine Life: Understanding Molecular Mechanisms and Therapeutic Potential
Kabir, M. T., Uddin, M. S., Jeandet, P., Emran, T. B., Mitra, S., Albadrani, G. M., Sayed, A. A., Abdel‐Daim, M. M., & Simal‐Gándara, J. (2021) · Marine Drugs · doi:10.3390/md19050251 · Cited by 65
Detection of singlet oxygen by EPR: The instability of the nitroxyl radicals
Victória, H. F. V., Ferreira, D. C., Filho, J. B. G., Martins, D. C. D. S., Pinheiro, M. V. B., Sáfar, G. A. M., & Krambrock, K. (2022) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.12.303 · Cited by 63
Polyphenol-induced dissociation of various amyloid fibrils results in a methionine-independent formation of ROS
Shoval, H., Weiner, L. M., Gazit, E., Levy, M., Pinchuk, I., & Lichtenberg, D. A. (2008) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2008.08.007 · Cited by 63
Melatonin prevents free radical formation due to the interaction between β‐amyloid peptides and metal ions [Al(III), Zn(II), Cu(II), Mn(II), Fe(II)]
Zatta, P. F., Tognon, G., & Carampin, P. (2003) · Journal of Pineal Research · doi:10.1034/j.1600-079x.2003.00058.x · Cited by 64
Relationships among Cortical Glutathione Levels, Brain Amyloidosis, and Memory in Healthy Older Adults Investigated In Vivo with1H-MRS and Pittsburgh Compound-B PET
Chiang, G. C.-Y., Mao, X., Kang, G., Chang, E., Pandya, S., Vallabhajosula, S., Isaacson, R., Ravdin, L., Initiative, A. D. N., & Shungu, D. C. (2017) · American Journal of Neuroradiology · doi:10.3174/ajnr.a5143 · Cited by 62
Cellular calcium signaling in the aging brain
Remya, C., Kumar, M., Kesavan, L., Jacob, R. S., Gunasekaran, S., Lakshmi, S., Sadasivan, C., & Omkumar, R. V. (2017) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2017.11.008 · Cited by 65
Novel synthetic chalcone‐coumarin hybrid for Aβ aggregation reduction, antioxidation, and neuroprotection
Lee, S., Chiu, Y., Yang, S., Chen, C., Huang, C., Lee‐Chen, G., Lin, W., & Chang, K. (2018) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13058 · Cited by 63
ERK activation and nuclear translocation in amyloid‐β peptide‐ and iron‐stressed neuronal cell cultures
Kuperstein, F., & Yavin, E. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.02056.x · Cited by 62
Comparison of cathepsin protease activities in brain tissue from normal cases and cases with Alzheimer's disease, Lewy body dementia, Parkinson's disease and Huntington's disease
Mantle, D., Falkous, G., Ishiura, S., Perry, R. H., & Perry, E. K. (1995) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(95)00035-z · Cited by 62
β-Amyloid-induced toxicity in rat hippocampal cells: In vitro evidence for the involvement of free radicals
Manelli, A. M., & Puttfarcken, P. S. (1995) · Brain Research Bulletin · doi:10.1016/0361-9230(95)02034-x · Cited by 62
From Anti-Parkinson's Drug Rasagiline to Novel Multitarget Iron Chelators with Acetylcholinesterase and Monoamine Oxidase Inhibitory and Neuroprotective Properties for Alzheimer's Disease
Zheng, H., Amit, T., Bar‐Am, O., Fridkin, M., Youdim, M. B. H., & Mandel, S. A. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120013 · Cited by 62
Ginsenoside Rg1 protection against β-amyloid peptide-induced neuronal apoptosis via estrogen receptor α and glucocorticoid receptor-dependent anti-protein nitration pathway
Wu, J., Pan, Z., Wang, Z., Zhu, W., Shen, Y., Cui, R., Lin, J., Yu, H., Wang, Q., Qian, J., et al. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.04.005 · Cited by 62
Self-citation
Inhibition of Catalase Activity with 3-Amino-Triazole Enhances the Cytotoxicity of the Alzheimer’s Amyloid-β Peptide
Milton, N. G. N. (2001) · NeuroToxicology · doi:10.1016/s0161-813x(01)00064-x · Cited by 62
Clinical importance of erythrocyte malondialdehyde levels as a marker for cognitive deterioration in patients with dementia of Alzheimer type: a repeated study in 5-year interval
Delibaş, N., Özçankaya, R., & Altuntaş, İ. (2002) · Clinical Biochemistry · doi:10.1016/s0009-9120(02)00287-4 · Cited by 61
Temporal Relations Among Amyloid β-Peptide-Induced Free-Radical Oxidative Stress, Neuronal Toxicity, and Neuronal Defensive Responses
Yatin, S. M., Aksenova, M. V., Aksenov, M. Y., Markesbery, W. R., Aulick, T., & Butterfield, D. A. (1998) · Journal of Molecular Neuroscience · doi:10.1385/jmn:11:3:183 · Cited by 62
Self-citation
Mitochondrial Disturbances, Tryptophan Metabolites and Neurodegeneration: Medicinal Chemistry Aspects
Szalárdy, L., Klivènyi, P., Zádori, D., Fülöp, F., Toldi, J., & Vécsei, L. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712800167365 · Cited by 60
Oxidative posttranslational modifications in Alzheimer disease
Smith, M. A., Sayre, L. M., Monnier, V. M., & Perry, G. L. (1996) · Molecular and Chemical Neuropathology · doi:10.1007/bf02815203 · Cited by 60
Vitamin D deficiency and Alzheimer disease: Common links
Keeney, J. T. R., & Butterfield, D. A. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.06.020 · Cited by 60
Self-citation
Cationic phosphorus dendrimers and therapy for Alzheimer's disease
Wasiak, T., Marcinkowska, M., Pieszyński, I., Zabłocka, M., Caminade, A., Majoral, J., & Klajnert‐Maculewicz, B. (2015) · New Journal of Chemistry · doi:10.1039/c5nj00309a · Cited by 59
Differential regulation of c-jun and CREB by acrolein and 4-hydroxynonenal
Pugazhenthi, S., Phansalkar, K., Audesirk, G. J., West, A. E., & Cabell, L. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.08.023 · Cited by 59
Accumulation of Exogenous Amyloid- Beta Peptide in Hippocampal Mitochondria Causes Their Dysfunction: A Protective Role for Melatonin
Rosales‐Corral, S., Acuña-Castroviejo, D., Tan, D. X., López-Armas, G. D. C., Cruz-Ramos, J. A., Munoz, R., Melnikov, V., Manchester, L. C., & Reiter, R. J. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/843649 · Cited by 61
Mitochondrial ferritin in neurodegenerative diseases
Yang, H., Yang, M., Guan, H., Liu, Z., Zhao, S., Takeuchi, S., Yanagisawa, D., & Tooyama, I. (2013) · Neuroscience Research · doi:10.1016/j.neures.2013.07.005 · Cited by 59
The molecular link between β- and γ-secretase activity on the amyloid β precursor protein
Tabaton, M., & Tamagno, E. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7219-3 · Cited by 62
Shikonin Protects PC12 Cells Against β-amyloid Peptide-Induced Cell Injury Through Antioxidant and Antiapoptotic Activities
Tong, Y., Bai, L., Gong, R., Chuan, J., Duan, X., & Zhu, Y. (2018) · Scientific Reports · doi:10.1038/s41598-017-18058-7 · Cited by 60
Tacrine hybrids as multi-target-directed ligands in Alzheimer’s disease: influence of chemical structures on biological activities
Girek, M. K., & Szymański, P. (2018) · Chemical Papers · doi:10.1007/s11696-018-0590-8 · Cited by 60
Neuroprotective effect ofH. perforatum extracts on β-amyloid-induced neurotoxicity
Silva, B. A., Dias, A. C. P., Ferreres, F., Malva, J. O., & Oliveira, C. R. (2004) · Neurotoxicity Research · doi:10.1007/bf03033214 · Cited by 58
Cellular cofactors potentiating induction of stress and cytotoxicity by amyloid β-peptide
Yan, S. D., Roher, A. E., Chaney, M., Zloković, B. V., Schmidt, A. M., & Stern, D. M. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(00)00041-7 · Cited by 58
Activity‐Dependent Neurotrophic Factor Peptide (ADNF9) Protects Neurons Against Oxidative Stress‐Induced Death
Glazner, G. W., Boland, A., Dresse, A., Brenneman, D. E., Gozes, I., & Mattson, M. P. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0732341.x · Cited by 58
Self-citation
Apoptosis, Neurotrophic Factors and Neurodegeneration
Dragunow, M., MacGibbon, G. A., Lawlor, P. A., Butterworth, N. J., Connor, B. J., Henderson, C. E., Walton, M. R., Woodgate, A.-M., Hughes, P. E., & Faull, R. L. M. (1997) · Reviews in the Neurosciences · doi:10.1515/revneuro.1997.8.3-4.223 · Cited by 58
A tombstone in Alzheimer's?
Mattson, M. P., Carney, J. M., & Butterfield, D. A. (1995) · Nature · doi:10.1038/373481a0 · Cited by 59
Self-citation
Syringin from stem bark of Fraxinus rhynchophylla protects Aβ(25–35)-induced toxicity in neuronal cells
Yang, E. J., Kim, S., Ku, H.-Y., Lee, D., Lee, J.-W., Kim, Y.-S., Seong, Y.-H., & Song, K. (2010) · Archives of Pharmacal Research · doi:10.1007/s12272-010-0406-z · Cited by 57
Perspectives on Oxidative Stress in Alzheimer’s Disease and Predictions of Future Research Emphases
Butterfield, D. A. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-179912 · Cited by 57
Self-citation
Influence of Acetylcholinesterase Inhibitors Used in Alzheimer’s Disease Treatment on the Activity of Antioxidant Enzymes and the Concentration of Glutathione in THP-1 Macrophages under Fluoride-Induced Oxidative Stress
Goschorska, M., Gutowska, I., Baranowska‐Bosiacka, I., Piotrowska, K., Metryka, E., Safranow, K., & Chlubek, D. (2018) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16010010 · Cited by 58
Lithostathine and pancreatitis-associated protein are involved in the very early stages of Alzheimer's disease
Duplan, L. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00182-2 · Cited by 57
Characterization of the signal transduction pathways mediating noradrenaline-stimulated MAPK activation and c-fos expression in oligodendrocyte progenitors
Khorchid, A., Larocca, J. N., & Almazán, G. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19991215)58:6 · Cited by 20
Amyloid ox–tox transducers
Mattson, M. P., & Rydel, R. E. (1996) · Nature · doi:10.1038/382674a0 · Cited by 57
Self-citation
Intracellular calcium signalling in Alzheimer’s disease
Hermes, M., Eichhoff, G., & Garaschuk, O. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00976.x · Cited by 57
The effects of white matter hyperintensities and amyloid deposition on Alzheimer dementia
Gordon, B. A., Najmi, S., Hsu, P. J., Roe, C. M., Morris, J. C., & Benzinger, T. L. S. (2015) · NeuroImage Clinical · doi:10.1016/j.nicl.2015.04.017 · Cited by 62
Toxicity mediated by soluble oligomers of β‐amyloid(1–42) on cholinergic SN56.B5.G4 cells
Heinitz, K., Beck, M., Schliebs, R., & Perez-Polo, J. R. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04015.x · Cited by 58
Amyloid β-Peptide-binding Alcohol Dehydrogenase Is a Component of the Cellular Response to Nutritional Stress
Yan, S. D., Zhu, Y., Stern, E., Hwang, Y. C., Hori, O., Ogawa, S., Frosch, M. P., Connolly, E. S., McTaggart, R., Pinsky, D. J., et al. (2000) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)61485-7 · Cited by 56
Micro- and Nanoplastics’ Effects on Protein Folding and Amyloidosis
Windheim, J., Colombo, L., Battajni, N. C., Russo, L., Cagnotto, A., Diomede, L., Bigini, P., Vismara, E., Fiumara, F., Gabbrielli, S., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810329 · Cited by 56
A Review of the Recent Advances in Alzheimer’s Disease Research and the Utilization of Network Biology Approaches for Prioritizing Diagnostics and Therapeutics
Hajjo, R., Sabbah, D. A., Abusara, O. H., & Bawab, A. Q. A. (2022) · Diagnostics · doi:10.3390/diagnostics12122975 · Cited by 57
Mechanism of neuroprotection of melatonin against beta-amyloid neurotoxicity
Йонов, М., Burchell, V., Klajnert‐Maculewicz, B., Bryszewska, M. J., & Abramov, A. Y. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.02.045 · Cited by 55
Astrocytes and endoplasmic reticulum stress: A bridge between obesity and neurodegenerative diseases
Martín-Jiménez, C., García-Vega, Á. S., Cabezas, R., Aliev, G., Echeverrı́a, V., González, J., & Barreto, G. E. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.08.001 · Cited by 56
Iron stored in ferritin is chemically reduced in the presence of aggregating Aβ(1-42)
Everett, J. L., Brooks, J., Lermyte, F., O’Connor, P. B., Sadler, P. J., Dobson, J., Collingwood, J. F., & Telling, N. D. (2020) · Scientific Reports · doi:10.1038/s41598-020-67117-z · Cited by 57
Paraoxonase 1 Activity: A New Vascular Marker of Dementia?
DANTOINE, T. F., Debord, J., Merle, L., LACROIX‐RAMIANDRISOA, H., Bernard‐Bourzeix, L., & Charmes, J. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04802.x · Cited by 55
Molecular mechanisms of oxidative stress in aging: free radicals, aging, antioxidants and disease
Pollack, M., & Leeuwenburgh, C. (2000) · Elsevier eBooks · doi:10.1016/b978-044482650-3/50030-4 · Cited by 57
Paraoxonase 1 192/55 Gene Polymorphisms in Alzheimer's Disease
DANTOINE, T. F., Drouet, M., Debord, J., Merle, L., Cogné, M., & Charmes, J. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04821.x · Cited by 54
New evidence that the Alzheimer β-amyloid peptide does not spontaneously form free radicals: An ESR study using a series of spin-traps
Turnbull, S., Tabner, B. J., El‐Agnaf, O. M. A., Twyman, L. J., & Allsop, D. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00510-x · Cited by 54
Aluminum but not iron treatment induces pro-oxidant events in the rat brain
Bondy, S. C., Ali, S. F., & Guo‐Ross, S. X. (1998) · Molecular and Chemical Neuropathology · doi:10.1007/bf02815081 · Cited by 54
Cross-talk between redox signalling and protein aggregation
van Dam, L., & Dansen, T. B. (2020) · Biochemical Society Transactions · doi:10.1042/bst20190054 · Cited by 56
Oxidative stress‐A direct bridge to central nervous system homeostatic dysfunction and Alzheimer's disease
Anwar, M. M. (2021) · Cell Biochemistry and Function · doi:10.1002/cbf.3673 · Cited by 54
Oxidative Stress: Glutathione and Its Potential to Protect Methionine-35 of Aβ Peptide from Oxidation
Mandal, P. K., Roy, R. G., & Samkaria, A. (2022) · ACS Omega · doi:10.1021/acsomega.2c02760 · Cited by 55
Effect of methionine-35 oxidation on the aggregation of amyloid-β peptide
Friedemann, M., Helk, E., Tiiman, A., Zovo, K., Palumaa, P., & Tõugu, V. (2015) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2015.07.017 · Cited by 53
Neuroprotective Effect of Neuropeptide Y against Beta-Amyloid 25–35 Toxicity in SH-SY5Y Neuroblastoma Cells Is Associated with Increased Neurotrophin Production
Croce, N., Dinallo, V., Ricci, V., Federici, G., Caltagirone, C., Bernardini, S., & Angelucci, F. (2011) · Neurodegenerative Diseases · doi:10.1159/000323468 · Cited by 53
Magnetite-Amyloid-β deteriorates activity and functional organization in an in vitro model for Alzheimer’s disease
Teller, S., Tahirbegi, I. B., Mir, M., Samitier, J., & Soriano, J. (2015) · Scientific Reports · doi:10.1038/srep17261 · Cited by 54
Effect of β-amyloid block of the fast-inactivating K + channel on intracellular Ca 2+ and excitability in a modeled neuron
Good, T. A., & Murphy, R. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.26.15130 · Cited by 53
Melatonin and Its Agonist Ramelteon in Alzheimer′s Disease: Possible Therapeutic Value
Srinivasan, V., Kaur, C., Pandi-Perumal, S. R., Brown, G. M., & Cardinali, D. P. (2010) · International Journal of Alzheimer s Disease · doi:10.4061/2011/741974 · Cited by 53
The relationship between the aggregational state of the amyloid‐β peptides and free radical generation by the peptides
Monji, A., Utsumi, H., Ueda, T., Imoto, T., Yoshida, I., Hashioka, S., Tashiro, K., & Tashiro, N. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00392.x · Cited by 53

Authors: Hensley, K., Carney, J. M., Mattson, M. P., Aksenova, M., Harris, M., Wu, J. F., Floyd, R. A., & Butterfield, D. A.
Affiliations: University of Kentucky (US)
Department of Chemistry, University of Kentucky, Lexington 40506.
ORCID: Mattson, M P
Aksenova, M
Butterfield, D A
Venue: Proceedings of the National Academy of Sciences
Publisher: National Academy of Sciences
Published: 1994-04-12
Volume: 91
Issue: 8
Pages: 3270-3274
ISSN: 0027-8424 (ISSN-L)
1091-6490
DOI: 10.1073/pnas.91.8.3270
PMC: PMC43558
OpenAlex: W2070117026
Cited by: 1,086
References: 23
Citations by year: 2026: 6 · 2025: 12 · 2024: 20 · 2023: 16 · 2022: 21 · 2021: 26 · 2020: 15 · 2019: 18 · 2018: 26 · 2017: 15 · 2016: 23 · 2015: 27 · 2014: 26 · 2013: 32 · 2012: 34
FWCI: 35.21
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Proceedings of the National Academy of Sciences (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: National Science Foundation (9108764)
Glenn Foundation for Medical Research
Fondation pour la Recherche Médicale
National Institutes of Health (AG-10836)
National Institute on Aging (AG 09690, P01AG010836, R01AG009690, AG 10836)
Office of Naval Research
National Institute of Neurological Disorders and Stroke (R01NS023307, NS-23307)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Prion Diseases and Protein Misfolding
Keywords: amyloid-beta, amyloid fibril formation, neurotoxicity, free radicals, reactive oxygen species, glutamine synthetase, creatine kinase, salicylate hydroxylation, amyloid plaques, Alzheimer's disease, peptide fragmentation, membrane alterations
MeSH terms: Alzheimer Disease, Amino Acid Sequence, Chromatography, High Pressure Liquid, Electron Spin Resonance Spectroscopy, Free Radicals, Gas Chromatography-Mass Spectrometry, Molecular Sequence Data, Neurotoxins, Salicylates, Amyloid beta-Peptides

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks